ProfessorNeil Poulter
Professor of Preventive Cardiovascular Medicine.
School of Public Health - Faculty of Medicine
Orcid identifier0000-0002-6292-997X (opens in a new tab)
- Professor of Preventive Cardiovascular Medicine.School of Public Health - Faculty of Medicine
- 020 7594 3446 (Work)
- 55, Stadium House, White City Campus, United Kingdom
BIO
Professor Neil Poulter qualified at St Mary’s Hospital, London, in 1974, following which he trained in General Medicine. He then spent 5 years in Kenya co-ordinating a collaborative hypertension research programme at the Wellcome Trust Research Laboratories in Nairobi.
On his return to the UK in 1985 he gained an MSc in Epidemiology with distinction at the London School of Hygiene and Tropical Medicine. Following this he was Co-PI of the WHO Oral Contraceptive case-control Study at University College London Medical School.
In 1997 he was appointed Professor of Preventive Cardiovascular Medicine at Imperial College London, where he is currently co-Director of the International Centre for Circulatory Health and Founding Director of the Imperial Clinical Trials Unit. He is an Honorary Consultant Physician and Epidemiologist at the Peart-Rose (CVD Prevention) Clinic based at Hammersmith Hospital, London, where he is actively involved in the treatment of patients with hypertension and related problems.
He was President of the British Hypertension Society from 2003-2005 and President of the International Society of Hypertension (2016-2018). In 2008, he was elected as one of the Inaugural Senior Investigators of the NIHR and also elected as a fellow of the Academy of Medical Sciences in 2009.
He has contributed chapters to several major textbooks and published over 700 papers in peer-reviewed medical journals, including co-authoring several sets of national and international guidelines. Professor Poulter was identified as being among the top 1% most cited academics in clinical medicine in 2014 (Thomson Reuters Highly Cited Researcher report) and among the top 0.1% most cited researcher between 2008-2024 (Web of Science Group Highly Cited Researcher).
He has played a senior management role in several international trials including the ASCOT, ADVANCE, EXSCEL, DEVOTE, LEADER, CREOLE, TOPSPIN and SOUL trials; other research activities include the optimal investigation and management of essential hypertension and dyslipidaemia; the association between birth weight and various cardiovascular risk factors; the cardiovascular effects of exogenous oestrogen and progesterone; the prevention and aetiology of type 2 diabetes and abdominal aortic aneurism; and ethnic differences in cardiovascular disease. He is the Chief Investigator of the May Measurement Month, an annual global blood pressure screening campaign initiated by the International Society of Hypertension.
On his return to the UK in 1985 he gained an MSc in Epidemiology with distinction at the London School of Hygiene and Tropical Medicine. Following this he was Co-PI of the WHO Oral Contraceptive case-control Study at University College London Medical School.
In 1997 he was appointed Professor of Preventive Cardiovascular Medicine at Imperial College London, where he is currently co-Director of the International Centre for Circulatory Health and Founding Director of the Imperial Clinical Trials Unit. He is an Honorary Consultant Physician and Epidemiologist at the Peart-Rose (CVD Prevention) Clinic based at Hammersmith Hospital, London, where he is actively involved in the treatment of patients with hypertension and related problems.
He was President of the British Hypertension Society from 2003-2005 and President of the International Society of Hypertension (2016-2018). In 2008, he was elected as one of the Inaugural Senior Investigators of the NIHR and also elected as a fellow of the Academy of Medical Sciences in 2009.
He has contributed chapters to several major textbooks and published over 700 papers in peer-reviewed medical journals, including co-authoring several sets of national and international guidelines. Professor Poulter was identified as being among the top 1% most cited academics in clinical medicine in 2014 (Thomson Reuters Highly Cited Researcher report) and among the top 0.1% most cited researcher between 2008-2024 (Web of Science Group Highly Cited Researcher).
He has played a senior management role in several international trials including the ASCOT, ADVANCE, EXSCEL, DEVOTE, LEADER, CREOLE, TOPSPIN and SOUL trials; other research activities include the optimal investigation and management of essential hypertension and dyslipidaemia; the association between birth weight and various cardiovascular risk factors; the cardiovascular effects of exogenous oestrogen and progesterone; the prevention and aetiology of type 2 diabetes and abdominal aortic aneurism; and ethnic differences in cardiovascular disease. He is the Chief Investigator of the May Measurement Month, an annual global blood pressure screening campaign initiated by the International Society of Hypertension.
ACADEMIC POSITIONS
- Professor of Preventive Cardiovascular MedicineImperial College London, National Heart and Lung and School of Public Health, London, United Kingdom1 Jan 1997 - present
- Co-Director of the International Centre for Circulatory HealthImperial College London, London, United Kingdom1 Jan 2004 - present
- Director of the Imperial Clinical Trials UnitImperial College London, London, United Kingdom2010 - present
NON-ACADEMIC POSITIONS
- Honorary Consultant Physician and EpidemiologistImperial College Healthcare NHS Trust, London, United Kingdom1986 - present
DEGREES
- MRCS LRCPUniveristy of London, United Kingdom1974 - present
- MBBSUniversity of London, London, United Kingdom1975 - present
- MScLondon School of Hygiene & Tropical Medicine, London, United Kingdom1986 - present
- FRCPRoyal College of Physicians, London, United Kingdom1995 - present
- F Med SciAcademy of Medical Science, London, United Kingdom2009 - present
FACULTY
- Faculty of Medicine
POSITION NAME
- Professor of Preventive Cardiovascular Medicine.